BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 37190249)

  • 1. P2X1 and P2X7 Receptor Overexpression Is a Negative Predictor of Survival in Muscle-Invasive Bladder Cancer.
    Ledderose S; Rodler S; Eismann L; Ledderose G; Rudelius M; Junger WG; Ledderose C
    Cancers (Basel); 2023 Apr; 15(8):. PubMed ID: 37190249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physiopathological implications of P2X
    Franco M; Bautista-Pérez R; Cano-Martínez A; Pacheco U; Santamaría J; Del Valle Mondragón L; Pérez-Méndez O; Navar LG
    Am J Physiol Renal Physiol; 2017 Jul; 313(1):F9-F19. PubMed ID: 28404593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Purinergic P2X
    Kulthinee S; Shao W; Franco M; Navar LG
    Am J Physiol Renal Physiol; 2020 Jun; 318(6):F1400-F1408. PubMed ID: 32308022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Purinergic 2X 4 (P2X4), but not P2X7, receptors increase cytosolic [Ca
    Fjærvoll HK; Fjærvoll KA; Yang M; Bair J; Utheim TP; Dartt DA
    Exp Eye Res; 2023 Oct; 235():109614. PubMed ID: 37580003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of long non-coding RNA TUG1 predicts poor prognosis and promotes cancer cell proliferation and migration in high-grade muscle-invasive bladder cancer.
    Iliev R; Kleinova R; Juracek J; Dolezel J; Ozanova Z; Fedorko M; Pacik D; Svoboda M; Stanik M; Slaby O
    Tumour Biol; 2016 Oct; 37(10):13385-13390. PubMed ID: 27460088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High P2X6 receptor expression in human bladder cancer predicts good survival prognosis.
    Dietrich F; Cappellari AR; Filippi-Chiela EC; de Paula PB; de Souza JB; Agatti SW; Andrejew R; Roesler R; Morrone FB; Battastini AMO
    Mol Cell Biochem; 2022 Aug; 477(8):2047-2057. PubMed ID: 35429327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional expression of P2X family receptors in macrophages is affected by microenvironment in mouse T cell acute lymphoblastic leukemia.
    Chen S; Feng W; Yang X; Yang W; Ru Y; Liao J; Wang L; Lin Y; Ren Q; Zheng G
    Biochem Biophys Res Commun; 2014 Apr; 446(4):1002-9. PubMed ID: 24661878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of the purinergic inhibitor oxidized ATP in a model of islet allograft rejection.
    Vergani A; Fotino C; D'Addio F; Tezza S; Podetta M; Gatti F; Chin M; Bassi R; Molano RD; Corradi D; Gatti R; Ferrero ME; Secchi A; Grassi F; Ricordi C; Sayegh MH; Maffi P; Pileggi A; Fiorina P
    Diabetes; 2013 May; 62(5):1665-75. PubMed ID: 23315496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ATP-evoked sustained vasoconstrictions mediated by heteromeric P2X1/4 receptors in cerebral arteries.
    Harhun MI; Povstyan OV; Albert AP; Nichols CM
    Stroke; 2014 Aug; 45(8):2444-50. PubMed ID: 25070962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systematic analysis of gene expression profiles reveals prognostic stratification and underlying mechanisms for muscle-invasive bladder cancer.
    Zhang PB; Huang ZL; Xu YH; Huang J; Huang XY; Huang XY
    Cancer Cell Int; 2019; 19():337. PubMed ID: 31866765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pre-clinical and clinical studies on the role of RBM3 in muscle-invasive bladder cancer: longitudinal expression, transcriptome-level effects and modulation of chemosensitivity.
    Wahlin S; Boman K; Moran B; Nodin B; Gallagher WM; Karnevi E; Jirström K
    BMC Cancer; 2022 Feb; 22(1):131. PubMed ID: 35109796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A promising independent prognostic biomarker in colorectal cancer: P2X7 receptor.
    Calik I; Calik M; Turken G; Ozercan IH
    Int J Clin Exp Pathol; 2020; 13(2):107-121. PubMed ID: 32211091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The P2X7 receptor regulates cell survival, migration and invasion of pancreatic ductal adenocarcinoma cells.
    Giannuzzo A; Pedersen SF; Novak I
    Mol Cancer; 2015 Nov; 14():203. PubMed ID: 26607222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of the urothelial differentiation marker FOXA1 is associated with high grade, late stage bladder cancer and increased tumor proliferation.
    DeGraff DJ; Clark PE; Cates JM; Yamashita H; Robinson VL; Yu X; Smolkin ME; Chang SS; Cookson MS; Herrick MK; Shariat SF; Steinberg GD; Frierson HF; Wu XR; Theodorescu D; Matusik RJ
    PLoS One; 2012; 7(5):e36669. PubMed ID: 22590586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. B7‑H3 promotes malignant progression of muscle‑invasive bladder cancer.
    Xu ZL; Zhang Y; Wang L; Li F; Man HW; Li PF; Shan BE
    Oncol Rep; 2018 Nov; 40(5):2722-2733. PubMed ID: 30132557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. P2X receptor overexpression induced by soluble oligomers of amyloid beta peptide potentiates synaptic failure and neuronal dyshomeostasis in cellular models of Alzheimer's disease.
    Sáez-Orellana F; Fuentes-Fuentes MC; Godoy PA; Silva-Grecchi T; Panes JD; Guzmán L; Yévenes GE; Gavilán J; Egan TM; Aguayo LG; Fuentealba J
    Neuropharmacology; 2018 Jan; 128():366-378. PubMed ID: 29079292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The P2X7 purinergic receptor: a potential therapeutic target for lung cancer.
    Li Q; Zhu X; Song W; Peng X; Zhao R
    J Cancer Res Clin Oncol; 2020 Nov; 146(11):2731-2741. PubMed ID: 32892231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential role of P2X7R in esophageal squamous cell carcinoma proliferation.
    Santos AA; Cappellari AR; de Marchi FO; Gehring MP; Zaparte A; Brandão CA; Lopes TG; da Silva VD; Pinto LFR; Savio LEB; Moreira-Souza ACA; Coutinho-Silva R; Paccez JD; Zerbini LF; Morrone FB
    Purinergic Signal; 2017 Sep; 13(3):279-292. PubMed ID: 28397110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic potentials and structure-activity relationship of 1,3-benzodioxole N-carbamothioyl carboxamide derivatives as selective and potent antagonists of P2X4 and P2X7 receptors.
    Mahmood A; Villinger A; Iqbal J
    Eur J Med Chem; 2022 Aug; 238():114491. PubMed ID: 35660250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maspin enhances cisplatin chemosensitivity in bladder cancer T24 and 5637 cells and correlates with prognosis of muscle-invasive bladder cancer patients receiving cisplatin based neoadjuvant chemotherapy.
    Chen J; Wang L; Tang Y; Gong G; Liu L; Chen M; Chen Z; Cui Y; Li C; Cheng X; Qi L; Zu X
    J Exp Clin Cancer Res; 2016 Jan; 35():2. PubMed ID: 26733306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.